Clostridia as live biotherapeutics: can modified Clostridium species enhance disease treatments?

Aleksandra M. Kubiak; Jella van de Laak; Yanchao Zhang; Tom S. Bailey; Luuk Claessen; Philip Hittmeyer; Carlijn Vlaswinkel; Alexsandra Mowday; Ludwig J. Dubois; Jan Theys

doi:10.2217/fmb-2022-0220

Clostridia as live biotherapeutics: can modified Clostridium species enhance disease treatments?

Aleksandra M. Kubiak
, Jella van de Laak
, Yanchao Zhang
, Tom S. Bailey
, Luuk Claessen
, Philip Hittmeyer
, Carlijn Vlaswinkel
, Alexsandra Mowday
, Ludwig J. Dubois
, Jan Theys^*

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › Academic › peer-review

Original language	English
Pages (from-to)	385-388
Number of pages	4
Journal	Future Microbiology
Volume	18
Issue number	7
Early online date	1 May 2023
DOIs	https://doi.org/10.2217/fmb-2022-0220
Publication status	Published - May 2023

Keywords

biotherapeutics
Clostridium
engineering
prevention
treatment

Access to Document

10.2217/fmb-2022-0220

Cite this

@article{cc5ca4b4a3284b4daa40ddbbb84cb37f,

title = "Clostridia as live biotherapeutics: can modified Clostridium species enhance disease treatments?",

keywords = "biotherapeutics, Clostridium, engineering, prevention, treatment",

author = "Kubiak, \{Aleksandra M.\} and \{van de Laak\}, Jella and Yanchao Zhang and Bailey, \{Tom S.\} and Luuk Claessen and Philip Hittmeyer and Carlijn Vlaswinkel and Alexsandra Mowday and Dubois, \{Ludwig J.\} and Jan Theys",

year = "2023",

month = may,

doi = "10.2217/fmb-2022-0220",

language = "English",

volume = "18",

pages = "385--388",

journal = "Future Microbiology",

issn = "1746-0913",